Big Call Screening: Beiersdorf, AXA, Procter & Gamble, Amphenol

Reading Time: 2 minutes
Beiersdorf is considered one of the beneficiaries of the emerging revival in consumer demand. With its strong core brand portfolio around Nivea, Eucerin, and Aquafor, it is very well positioned in both the consumer and high-margin dermatology segments. Thanks to the new anti-aging series Hyaluron-Filler Epigenetic Serum, which has been proven to reduce the signs of skin aging, it is also very well set in this growth segment. As consumer demand in China continues to brighten, Beiersdorf is likely on the verge of a trend reversal there, which is why...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.